C57BL/6JCya-Ergic3em1/Cya
Common Name
Ergic3-KO
Product ID
S-KO-19260
Backgroud
C57BL/6JCya
Strain ID
KOCMP-66366-Ergic3-B6J-VB
When using this mouse strain in a publication, please cite “Ergic3-KO Mouse (Catalog S-KO-19260) were purchased from Cyagen.”
Product Type
Age
Genotype
Sex
Quantity
Basic Information
Strain Name
Ergic3-KO
Strain ID
KOCMP-66366-Ergic3-B6J-VB
Gene Name
Product ID
S-KO-19260
Gene Alias
2310015B14Rik, CGI-54, D2Ucla1, NY-BR-84, Sdbcag84
Background
C57BL/6JCya
NCBI ID
Modification
Conventional knockout
Chromosome
Chr 2
Phenotype
Datasheet
Application
--
Strain Description
Ensembl Number
ENSMUST00000088650
NCBI RefSeq
NM_001356413
Target Region
Exon 5
Size of Effective Region
~0.4 kb
Overview of Gene Research
Ergic3, also known as endoplasmic reticulum-Golgi intermediate compartment 3, is a type II transmembrane protein located in the endoplasmic reticulum and Golgi body. It is involved in the ER-to-Golgi transport, especially for gap junction proteins, and may participate in protein kinase-coupled receptors mediated signal transduction pathways [2,3]. Its abnormal expression is related to cancer development, making it a potential biomarker and therapeutic target.
Knockdown of Ergic3 in lung cancer cell lines and in a murine model of lung cancer led to endoplasmic reticulum stress-induced autophagic cell death and suppression of cell growth and tumorigenesis [1,4]. In hepatocellular carcinoma cells, Ergic3 knockdown affected the expression of genes involved in vesicular transport, growth factors, and immune-related pathways [3].
In conclusion, Ergic3 is crucial for the ER-to-Golgi transport of specific proteins. Studies with Ergic3 knockdown models have revealed its significant role in cancer, especially in lung and liver cancers, suggesting that targeting Ergic3 could be a potential strategy for cancer treatment.
References：
1. Zhao, Qiurong, Wu, Mingsong, Zheng, Xiang, Li, Xueying, Chen, Jindong. . ERGIC3 Silencing Additively Enhances the Growth Inhibition of BFA on Lung Adenocarcinoma Cells. In Current cancer drug targets, 20, 67-75. doi:10.2174/1568009619666190917145906. https://pubmed.ncbi.nlm.nih.gov/31530266/
2. Guan, Liying, Yang, Yongzhi, Liang, Jingjing, Wang, Yingchun, Ding, Mei. 2022. ERGIC2 and ERGIC3 regulate the ER-to-Golgi transport of gap junction proteins in metazoans. In Traffic (Copenhagen, Denmark), 23, 140-157. doi:10.1111/tra.12830. https://pubmed.ncbi.nlm.nih.gov/34994051/
3. Liu, Mengyuan, Zhao, Qiurong, Zheng, Xiang, Li, Xueying, Wu, Mingsong. 2022. Transcriptome changes in ERGIC3-knockdown hepatocellular carcinoma cells: ERGIC3 is a novel immune function related gene. In PeerJ, 10, e13369. doi:10.7717/peerj.13369. https://pubmed.ncbi.nlm.nih.gov/35602902/
4. Hong, Seong-Ho, Chang, Seung-Hee, Cho, Kyung-Cho, Park, Jongsun, Cho, Myung-Haing. . Endoplasmic reticulum-Golgi intermediate compartment protein 3 knockdown suppresses lung cancer through endoplasmic reticulum stress-induced autophagy. In Oncotarget, 7, 65335-65347. doi:10.18632/oncotarget.11678. https://pubmed.ncbi.nlm.nih.gov/27588471/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.